Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.
about
Clot lysis phenotype and response to recombinant factor VIIa in plasma of haemophilia A inhibitor patients.An in-vitro assessment of tranexamic acid as an adjunct to rFVIII or rFVIIa treatment in haemophilia A.Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors.FXIII: mechanisms of action in the treatment of hemophilia A.Light-chain amyloidosis presenting as a change in bleeding phenotype in a patient with mild haemophilia A.Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway.
P2860
Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.
@ast
Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.
@en
type
label
Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.
@ast
Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.
@en
prefLabel
Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.
@ast
Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.
@en
P2093
P2860
P1433
P1476
Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.
@en
P2093
G E Rivard
K E Brummel-Ziedins
M E Nesheim
P2860
P304
P356
10.1111/J.1365-2516.2011.02648.X
P577
2011-09-20T00:00:00Z